Ratings
0
Nobody has rated this yet. Be the first!
Works
12
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Shared heritability and functional enrichment across six solid cancers
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
The epigenetics of breast cancer
Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma
Mutations for the people
Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer
The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.
